Oleate Promotes Triple-Negative Breast Cancer Cell Migration by Enhancing Filopodia Formation through a PLD/Cdc42-Dependent Pathway.
Zhiqiang GuoKarl-Frédérik BergeronCatherine MounierPublished in: International journal of molecular sciences (2024)
Breast cancer, particularly triple-negative breast cancer (TNBC), poses a global health challenge. Emerging evidence has established a positive association between elevated levels of stearoyl-CoA desaturase 1 (SCD1) and its product oleate (OA) with cancer development and metastasis. SCD1/OA leads to alterations in migration speed, direction, and cell morphology in TNBC cells, yet the underlying molecular mechanisms remain elusive. To address this gap, we aim to investigate the impact of OA on remodeling the actin structure in TNBC cell lines, and the underlying signaling. Using TNBC cell lines and bioinformatics tools, we show that OA stimulation induces rapid cell membrane ruffling and enhances filopodia formation. OA treatment triggers the subcellular translocation of Arp2/3 complex and Cdc42. Inhibiting Cdc42, not the Arp2/3 complex, effectively abolishes OA-induced filopodia formation and cell migration. Additionally, our findings suggest that phospholipase D is involved in Cdc42-dependent filopodia formation and cell migration. Lastly, the elevated expression of Cdc42 in breast tumor tissues is associated with a lower survival rate in TNBC patients. Our study outlines a new signaling pathway in the OA-induced migration of TNBC cells, via the promotion of Cdc42-dependent filopodia formation, providing a novel insight for therapeutic strategies in TNBC treatment.
Keyphrases
- cell migration
- knee osteoarthritis
- induced apoptosis
- cell cycle
- signaling pathway
- global health
- cell cycle arrest
- end stage renal disease
- public health
- newly diagnosed
- chronic kidney disease
- diabetic rats
- poor prognosis
- pi k akt
- oxidative stress
- drug induced
- endoplasmic reticulum stress
- papillary thyroid
- cell proliferation
- gene expression
- young adults
- mesenchymal stem cells
- cell death
- fatty acid
- peritoneal dialysis
- patient reported outcomes